Md Istiaq Ansari

Md Istiaq Ansari

Auto-generated profile, based on publicly available information

Md Istiaq Ansari

Department of Computer Science, University of Central Florida, Central Florida Blvd, Orlando, Florida, United States of America

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
Farhat Binte AzamFarhat Binte Azam
Farhat Binte Azam
IAIstiaq Ansari
Istiaq Ansari
SNShoyad Ibn Sabur Khan Nuhash
Shoyad Ibn Sabur Khan Nuhash
IMIan McLane
Ian McLane
THTaufiq Hasan
Taufiq Hasan

22 June 2026 in PLOS Computational Biology
Verified
Journal Article
Open access
MAMd Istiaq Ansari
Md Istiaq Ansari
KAKhandakar Tanvir Ahmed
Khandakar Tanvir Ahmed
DWDebby D. Wang
Debby D. Wang
KMKirill Medvedev
Kirill Medvedev
WZWei Zhang
Wei Zhang
Protein isoforms produced from the same gene through post-transcriptional regulatory mechanisms, such as alternative splicing, can substantially alter protein structure and function, including drug-binding properties. However, most existing drug-target interaction (DTI) and drug-target affinity (DTA) prediction models rely exclusively on a single representative protein sequence per gene, typically the canonical or longest isoform, thereby overlooking the functional diversity introduced by alternative isoforms. This assumption can introduce bias, limit generalizability, and compromise the biological validity of model predictions. In this study, we systematically investigate the impact of protein isoform variation on DTI prediction accuracy. Our results show that substituting the canonical sequence with an alternative isoform often leads to substantial declines in predictive performance. Structural and binding affinity analyses further reveal that these discrepancies are frequently associated with changes in predicted binding-site configurations, which we further examine through controlled perturbations of binding-site residues. These experiments suggest that even subtle alterations in binding regions can lead to inconsistent DTI predictions. Overall, our findings uncover a critical limitation in current DTI modeling frameworks and underscore the importance of incorporating isoform-specific information to better reflect biological reality and improve therapeutic relevance. The codes and datasets are available at https://github.com/compbiolabucf/DTIVariant .